Immune-mediated cholangitis: is it always nivolumab’s fault?
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-018-2159-3
Abstract: We read with much interest the article published by Kashima and colleagues on “Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small cell lung cancer: a case report” [1].… read more here.
Keywords: disease; case; related cholangitis; cholangitis ... See more keywords
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "Investigational New Drugs"
DOI: 10.1007/s10637-017-0453-0
Abstract: SummaryBackground Nivolumab demonstrates promising efficacy for the treatment of non-small cell lung cancer and other malignancies. The clinical benefit of nivolumab, however, may be hampered by specific immune-related adverse events (irAEs), and little is known… read more here.
Keywords: nivolumab related; related cholangitis; cholangitis; non small ... See more keywords
Pembrolizumab-related cholangitis with multiple fatal liver abscesses after endoscopic biliary drainage: a case report and review of the literature
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Journal of Gastroenterology"
DOI: 10.1007/s12328-022-01593-w
Abstract: A 60-year-old male with cStage IVB lung cancer was treated with pembrolizumab. However, after five courses of pembrolizumab, he developed pembrolizumab-related cholangitis. Imaging studies showed enlargement and diffuse wall thickening of the gallbladder and mild… read more here.
Keywords: biliary drainage; cholangitis; liver abscesses; related cholangitis ... See more keywords
Successful Treatment of Nivolumab-related Cholangitis with Prednisolone: A Case Report and Review of the Literature
Sign Up to like & getrecommendations! Published in 2019 at "Internal Medicine"
DOI: 10.2169/internalmedicine.2330-18
Abstract: The patient was a 76-year-old man who was treated with nivolumab due to recurrent gastric cancer. A blood examination revealed grade 3 alkaline phosphatase (ALP) elevation. A histopathological examination revealed marked portal infiltration, including eosinophils… read more here.
Keywords: successful treatment; nivolumab related; related cholangitis; prednisolone ... See more keywords